bioAffinity Technologies, Inc. Stock
Equities
BIAF
US09076W1099
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.97 USD | -1.50% | 0.00% | +33.97% |
Financials (USD)
Sales 2022 | 0 | Sales 2023 | 2.53 | Capitalization | 13.97M |
---|---|---|---|---|---|
Net income 2022 | -8M | Net income 2023 | -7M | EV / Sales 2022 | 464,207,162 x |
Net cash position 2022 | 11.16M | Net cash position 2023 | 1.24M | EV / Sales 2023 | 5,026,702 x |
P/E ratio 2022 |
-0.88
x | P/E ratio 2023 |
-1.62
x | Employees | 14 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 64.96% |
Latest transcript on bioAffinity Technologies, Inc.
1 day | -0.25% | ||
1 week | +1.02% | ||
Current month | -18.78% | ||
1 month | -27.90% | ||
3 months | +30.92% | ||
6 months | +38.83% | ||
Current year | +35.33% |
Managers | Title | Age | Since |
---|---|---|---|
Maria Zannes
FOU | Founder | 68 | 14-03-25 |
Director of Finance/CFO | 45 | 23-04-30 | |
David Elzi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Girgenti
CHM | Chairman | 78 | 14-02-28 |
Peter Knight
BRD | Director/Board Member | 73 | 18-04-30 |
Stuart Diamond
BRD | Director/Board Member | 63 | 21-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 1.97 | -1.50% | 72 324 |
24-05-10 | 2 | -0.99% | 81,821 |
24-05-09 | 2.02 | -2.42% | 103,011 |
24-05-08 | 2.07 | -0.48% | 43,641 |
24-05-07 | 2.08 | +5.58% | 87,405 |
Delayed Quote Nasdaq, May 13, 2024 at 12:31 pm EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+35.33% | 23.03M | |
-3.58% | 12.64B | |
-1.48% | 8.46B | |
+8.70% | 5.66B | |
+24.27% | 5.27B | |
-4.58% | 4.49B | |
-51.47% | 3.11B | |
+16.25% | 2.87B | |
+30.98% | 2.31B | |
-4.08% | 1.89B |
- Stock Market
- Equities
- BIAF Stock